NewAmsterdam Historical Financial Ratios
| NAMS Stock | 20.20 0.08 0.40% |
NewAmsterdam Pharma is lately reporting on over 85 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 6.3 will help investors to properly organize and evaluate NewAmsterdam Pharma financial condition quickly.
NewAmsterdam |
About NewAmsterdam Financial Ratios Analysis
NewAmsterdam PharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate NewAmsterdam Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on NewAmsterdam financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across NewAmsterdam Pharma history.
NewAmsterdam Pharma Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing NewAmsterdam Pharma stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on NewAmsterdam Pharma sales, a figure that is much harder to manipulate than other NewAmsterdam Pharma multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from NewAmsterdam Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into NewAmsterdam Pharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.At this time, NewAmsterdam Pharma's Ebt Per Ebit is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.02 in 2024, despite the fact that Free Cash Flow Per Share is likely to grow to (1.63).
| 2023 | 2024 (projected) | Graham Number | 13.04 | 10.2 | Receivables Turnover | 41.7 | 37.06 |
NewAmsterdam Pharma fundamentals Correlations
Click cells to compare fundamentals
NewAmsterdam Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.